Skip to content
10-K

Annual Report

60 DEGREES PHARMACEUTICALS, INC. SXTP SXTPW

0001013762-25-003343

← back to feed
Filed
Mar 27, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 27, 2025 1.47M sh
Shares Diluted restated FY 2024 · Dec 31, 2023 66.31K sh
Capex FY 2024 · Dec 31, 2023 $57.62K
Operating Cash Flow FY 2024 · Dec 31, 2023 −$4.54M
Cash And Equivalents FY 2024 · Dec 31, 2023 $2.14M
Stockholders Equity FY 2024 · Dec 31, 2023 $4.87M
Current Liabilities FY 2024 · Dec 31, 2023 $2.84M
Total Liabilities FY 2024 · Dec 31, 2023 $2.99M
Current Assets FY 2024 · Dec 31, 2023 $7.24M
Total Assets FY 2024 · Dec 31, 2023 $7.78M
Eps Diluted restated FY 2024 · Dec 31, 2023 −$59.18
Eps Basic restated FY 2024 · Dec 31, 2023 −$59.18
Sga Expense FY 2024 · Dec 31, 2023 $4.24M
Rd Expense FY 2024 · Dec 31, 2023 $691.77K
Net Income FY 2024 · Dec 31, 2023 −$3.77M
Operating Income FY 2024 · Dec 31, 2023 −$5.15M
Gross Profit FY 2024 · Dec 31, 2023 −$220.98K
Cost Of Revenue FY 2024 · Dec 31, 2023 $474.55K
Revenue FY 2024 · Dec 31, 2023 $253.57K
Short Term Debt FY 2024 · Apr 30, 2023 $50K
Short Term Debt FY 2024 · Mar 31, 2023 $200K